PME Brings Visage 7 Open Archive to North America

18 May 2017; Company Announcement - PME Introduces Visage 7 Open Archive - Acrobat pdf 81k Highlights Built on the same ultrafast, highly scalable enterprise imaging platform used in Visage 7. Modular design based on open standards ensures maximum interoperability even in the most complex environments. Already in use in many large scale implementations outside the U.S. Enables Visage to offer choice of deconstructed or single vendor solutions. Well placed to fill the needs of a rapidly changing North American archive market. Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly owned U.S. subsidiary, Visage Imaging, Inc., has introduced Visage 7 Open Archive in North America. Already in use at many large-scale implementations outside the U.S., Visage 7 Open Archive delivers ultrafast access to images and industry-leading scalability all within a modular, open standards framework. “With Visage 7, we’ve set the benchmark when it comes to speed, functionality and scalability,“ said Malte Westerhoff, PhD, Co-founder and Global CTO of Visage Imaging. “The archive is an integral part of an enterprise imaging strategy, so it too must have the necessary performance, interoperability and scalability. We have been able to achieve this with Visage 7 Open Archive by utilising the same enterprise imaging platform that has made Visage 7 so successful, whilst at the same time ensuring that it is open standards based.” Visage 7 Open Archive closely couples the storage of images to Visage 7 to provide performance and interoperability unmatched by others. “Unlike legacy PACS vendors, we have offered a modular or deconstructed solution that provides our clients with the flexibility to choose the technology components that best suits their needs,” said Dr Sam Hupert, Pro Medicus CEO. “To date, we have replaced more than 40

Pro Medicus Signs Key US Contract

4 July 2016; Company Announcement Pro Medicus Signs Mayo Clinic - Acrobat pdf 123k Key Points PME signs 6 year deal with Mayo Clinic in the US Visage 7 to be implemented enterprise-wide throughout Mayo Clinic’s Radiology departments Estimated value to PME in excess of AUD $18 million Transaction-based model with potential upside Third major US deal in 4 months Recent deals reposition PME in US market Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly owned US subsidiary, Visage Imaging, Inc., has signed an AUD $18 million, six-year contract with Mayo Clinic. The contract, based on a transaction licensing model, will see Pro Medicus’ Visage 7 technology implemented across Mayo Clinic’s Radiology practices. Project planning has begun with the first sites scheduled to move into production in the second quarter of FY2017 with the remaining sites rolling out over an 18 month period with project completion set for the fourth quarter of FY2018. “This is a very significant contract for us and further validates our belief that Visage 7 is uniquely positioned to cater for the needs of the most sophisticated and demanding clinical environments,” said Dr Sam Hupert, Pro Medicus CEO. “It has the speed and functionality to meet the requirements of a large and diverse group of high-end clinical users as well as the scalability to handle the huge data volumes that a medical enterprise of this size generates”. Dr Hupert continued, “This is the third major deal we have signed in the past few months following our recent Mercy and FMOLHS announcements, and further cements our growing footprint in the North American market. With this deal we have reached another major milestone in terms of market acceptance and we look to build on this

PharmacySydney.com MJDHealthPharmacy.com
Go to Top